| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/03/2000 | EP0687302B1 Bi-functional expression system |
| 05/03/2000 | EP0669977B1 Transformed endothelial cells |
| 05/03/2000 | EP0668908B1 Specific dna sequences of a nematode which can be used for the diagnosis of infection with the nematode |
| 05/03/2000 | EP0624100B1 Dna encoding a human serotonin receptor (5-ht 4b) and uses thereof |
| 05/03/2000 | EP0620863B1 Manipulating nucleic acid sequences |
| 05/03/2000 | EP0612350B1 Ubiquitin-specific proteases |
| 05/03/2000 | EP0567630B1 Dna-sequence coding for carminomycin 4-o-methyltransferase |
| 05/03/2000 | EP0559884B1 Viral recombinant vectors for expression in muscle cells |
| 05/03/2000 | EP0514481B1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 05/03/2000 | EP0460042B1 Vector for integration site independent gene expression in mammalian host cells |
| 05/03/2000 | CN1252104A Selective ligation and amplification |
| 05/03/2000 | CN1252103A Characterising DNA |
| 05/03/2000 | CN1252102A DNA construct to confer multiple traits on plants |
| 05/03/2000 | CN1252101A Component of bromelain |
| 05/03/2000 | CN1252100A Recombinant haloaliphatic dehalogenases |
| 05/03/2000 | CN1252099A Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 05/03/2000 | CN1252098A Soybean plant producing seeds with reduced levels of raffinose saccharides and phytic acid |
| 05/03/2000 | CN1252097A Selection for transgenic plants |
| 05/03/2000 | CN1252096A Component of bromelain |
| 05/03/2000 | CN1252076A Production of antihuman antigen receptors and use thereof |
| 05/03/2000 | CN1252075A Synthetic HIV GAG genes |
| 05/03/2000 | CN1252006A Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 05/03/2000 | CN1251862A Soybean pollen tube channel transgene and its variety improving technique |
| 05/03/2000 | CN1251861A Human T cell activating protein gene and its coded polypeptide, preparing process and application |
| 05/03/2000 | CN1251860A Human gene sequence and its coded polypeptide, preparing process and application |
| 05/03/2000 | CN1251840A Constitutive fusion protein of ridamycin as anticancer antibiotic and single-chain antibody |
| 05/03/2000 | CN1251839A Activating agent for methanol dehydrogenase and genes thereof |
| 05/02/2000 | US6057610 Lighter plug DC outlet and single AC and DC plug with adapter circuit |
| 05/02/2000 | US6057496 Biasing plant crops with codes for resistance to translocatable herbicides |
| 05/02/2000 | US6057494 Nucleotide sequence which encodes 1-sucrose:sucrose fructosyltransferase; for transformed organisms showing a modified fructan profile |
| 05/02/2000 | US6057493 Plasmids, plants and plant cells expressing anti-sense patatin and anti-sense ADP-glucose pyrophosphorylase sequences |
| 05/02/2000 | US6057492 Plants resistant to tospoviruses |
| 05/02/2000 | US6057491 Protein having insecticidal activities and method of use |
| 05/02/2000 | US6057490 Evaluating expression of reporter gene under regulation of systemic acquired resistance gene promoter in uninfected, phenotypically normal plants, and selecting plants that constitutively express gene in absence of infections |
| 05/02/2000 | US6057489 MmRad51-deficient cells and transgenic mice |
| 05/02/2000 | US6057437 Antisense nucleic acid compounds inhibiting vascular endothelial growth factor |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057434 Polynucleotide which encodes a protein of specific amino acid sequence; for anticarcinogenic/antitumor agents, diagnostic and screening assays |
| 05/02/2000 | US6057433 Nucleotide sequences; used for screening compounds which bind to the receptor or which suppress ligand binding to the receptor |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057428 Variants of vascular endothelial cell growth factor |
| 05/02/2000 | US6057427 Antibody or fragment which binds to specific amino acid sequence; for peptide/protein purification |
| 05/02/2000 | US6057426 Nucleotide and amino acid sequences of polypeptide capable of inducing leukocyte migration and/or activating leukocytes in a dose-dependent manner; diagnosis/screening/therapy; for increasing cell layer permeability for drug circulation |
| 05/02/2000 | US6057423 Screening a recombinantly-produced or chemically-synthesized molecular library to identify compounds which suppress binding between human mucosal lymphocyte-1 antigen comprising an integrin alpha e chain and an epithelial cell in vitro |
| 05/02/2000 | US6057300 Introducing expression vector comprising gene encoding p21 and expression vector comprising second gene encoding immunotherapeutic agent, genetic therapeutic, cytokine or prodrug converting enzyme to treat restenosis |
| 05/02/2000 | US6057299 Isolated polynucleotide comprising prostate-specific enhancer which activates transcription of nucleotide sequence in human prostate cell, operably linked to polynucleotide sequence encoding heterologous polypeptide |
| 05/02/2000 | US6057298 Administering to treat skin cancer |
| 05/02/2000 | US6057292 Method for inhibiting growth hormone action |
| 05/02/2000 | US6057288 N-(3-oxododecanoyl)homoserine lactone, useful for treating or preventing infection by pseudomonas aeruginosa |
| 05/02/2000 | US6057287 Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| 05/02/2000 | US6057158 Mammalian cell line having a recombinant plasmid with inverted terminal repeats, packaging sequences, and gene of interest and a helper adenovirus having loxp sequences and packaging sequences; for improved gene therapy |
| 05/02/2000 | US6057156 Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors |
| 05/02/2000 | US6057155 Nucleic acid encoding a chimeric adenovirus fiber protein constrained by a non-preexisting loop; for efficient, direct entry of the nucleic acid-containing vector into cells for targeted gene therapy |
| 05/02/2000 | US6057153 Oligonucleotide composed of modified nucleotides and having a ribonuclease p cleavage targeting sequence and a recognition sequence complementary to target rna; for viricides to treat hepatitis b infections |
| 05/02/2000 | US6057152 Recombinant viral vector system |
| 05/02/2000 | US6057146 Rhizobium/agrobacterium containing a hybrid plasmid having dna coding for a protein which confers ability to grow on media containing betaines as sole carbon and/or nitrogen source |
| 05/02/2000 | US6057144 Chitin deacetylase gene, vector containing said gene and transformant |
| 05/02/2000 | US6057143 Recombinant enzymatically active calpain expressed in a baculovirus system |
| 05/02/2000 | US6057142 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 05/02/2000 | US6057136 Biotin biosynthesis in Bacillus subtilis |
| 05/02/2000 | US6057133 Fusion protein associated with cell growth and regulation; for the activation of bone marrow propagation; for treatment of cancer, asthma and inflammation |
| 05/02/2000 | US6057132 Nucleotide sequences encoding apoptosis associated Bbk protein |
| 05/02/2000 | US6057131 Preparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1) |
| 05/02/2000 | US6057130 Method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 05/02/2000 | US6057128 MU-1, member of the cytokine receptor family |
| 05/02/2000 | US6057127 Mammalian nucleotide sequences that code for antibody binding protein; for detection of antibody and immune response; for the diagnosis of allergies, parasitic infections and tumors |
| 05/02/2000 | US6057126 Polynucleotide sequence coding human binding polypeptide associated with signal transduction; for treatment and prevention of cancer, inflammation, psoriasis and arthritis; wound healing agents; antiproliferative agents |
| 05/02/2000 | US6057124 Nucleic acids encoding ligands for HEK4 receptors |
| 05/02/2000 | US6057123 Stem cell inhibiting proteins |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6057119 Detecting modulators of a mutant interleukin enzyme; using a three dimensional structure of interleukin enzyme, adjusting amino acid sequence, choosing and synthesizing modulator, incubating with mutant to test efficiency of enzyme inhibitor |
| 05/02/2000 | US6057113 Soluble transmembrane glycoprotein and variants associated with signal transduction and suppression of signal transduction |
| 05/02/2000 | US6057112 Ubiquitin conjugation proteins |
| 05/02/2000 | US6057111 Detection of genes for maintenance of specific cell phenotypes; isolating cell type with phenotype of interest, deactivating genes, isolating cells which maintain phenotype, use subtractive analysis to screen for maintainence gene |
| 05/02/2000 | US6057110 Human hyaluronidase |
| 05/02/2000 | US6057109 Compositions for the treatment of body weight disorders including obesity |
| 05/02/2000 | US6057108 Human ARF-related proteins |
| 05/02/2000 | US6057104 Disruption of the mammalian Rad51 protein and disruption of proteins that associate with mammalian Rad51 for hindering cell proliferation |
| 05/02/2000 | US6057103 Detecting proteins coded in genomic nucleotide sequences; obtaining single stranded nucleotide sequences, incubating with probe, isolating bound nucleotide sequences, transforming cells, recovering desired proteins |
| 05/02/2000 | US6057101 Identification and comparison of protein-protein interactions that occur in populations and identification of inhibitors of these interactors |
| 05/02/2000 | US6057098 Preparing genetically engineered phage envelope protein; providing phage packages coding varying number of envelope protein, contacting the library with a receptor, separating phage packages |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | US6057093 Genetically engineering nucleotide sequences for efficient protein synthesis of viral genes; linking a conserved nucleotide sequence to the terminal end of a ribonucleic acid sequence and activating protein synthesis |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056957 Humanized monoclonal antibodies against human interleukin-5 |
| 05/02/2000 | US6056953 Materials and methods for the control of calliphoridae pests |
| 05/02/2000 | US6056952 Selective elimination of T cells that recognize specific preselected targets |
| 05/02/2000 | US6056938 Cationic lipids and the use thereof |
| 05/02/2000 | CA2207065C Strand displacement amplification using boronated nucleotides |
| 05/02/2000 | CA2168914C Fusion proteins of immunopotentiating activity |
| 05/02/2000 | CA2105057C Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 05/02/2000 | CA2104014C Structural gene of pneumococcal protein |
| 05/02/2000 | CA2093424C Methods for treating cotton-containing fabrics with cellulase |
| 05/02/2000 | CA2076018C Docosahexaenoic acid, methods for its production and compounds containing the same |
| 05/02/2000 | CA2071213C High temperature reverse transcriptases |
| 05/02/2000 | CA2054030C Protease from bacillus licheniformis |
| 05/02/2000 | CA2017636C Derivative of tissue-type plasminogen activator |
| 05/02/2000 | CA2012170C Novel method of ovulation induction in humans |
| 05/02/2000 | CA2011878C Immunogenic regions on the e7 protein of human papillomavirus type 16 |
| 05/02/2000 | CA1340982C Protamine-reactive igm antibodies |